Gameto is a biotechnology company translating the impact of ovarian aging to develop solutions to improve fertility and stop the impact of menopause on female health.
Gameto's scientific work involves reconstituting ovarian development and function in vitro, elucidating the underlying growth factor and genetic networks that drive human ovarian development and oogenesis. We aim to leverage our allogeneic human cellular derivatives of our platform to therapeutic applications for assisted fertility and menopause.
- Dr. Dina Radenkovic
- Martin Varsavsky
- Age at #menopause is linked to #lifespan. Our friend and collaborator @karagoldmanMD on the quest for biomarkers li… https://t.co/d7yETqjN0H
- Fascinating article on the importance of sex in research on how pregnancy conditions affect metabolic health, leadi… https://t.co/eF6p9xlaoq
- Incredible new insights into post-implantation embryonic development through spatial transcriptomic profiling of th… https://t.co/XBAIJItd2w